Delivery Order SPE2DB22D2006-SPE2DB25FW2NG
Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $5,991.41 and a completion date of July 14, 2025. The contract is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $1,024.77 and is a firm fixed-price, non-set-aside award with a period of performance through July 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication, with a firm fixed price of $1,848.78 and a completion date of May 15, 2025. The contract is not set aside and was awarded on May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE UD 100S, a pharmaceutical product, with a ceiling value of $13,155.36 and a performance period ending on July 11, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not set aside for any specific business type....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract is for the delivery of RIFAMPIN 300 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $4,432.36. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp is a large,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300 MG CAPSULE UD 100S. The contract has a firm fixed price, a ceiling value of $11,383.20, and an ultimate completion date of June 24, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania,...
- This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of Rifampin 300mg capsules, a pharmaceutical product, with a ceiling value of $106,743.73 and a performance period through June 18, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RIFAMPIN 300MG CAP 60S. The contract has a ceiling value of $7,350.32 and is a firm fixed-price delivery order, with an ultimate completion date of August 1, 2025. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,418.27, is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract has a period of performance through June 6, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $3,733.98 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is to provide RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set-aside and was awarded on June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...